GCO — Genesco Balance Sheet
0.000.00%
- $303.70m
- $201.68m
- $2.44bn
Annual balance sheet for Genesco, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2022 January 29th | 2023 January 28th | 2024 February 3rd | 2025 February 1st | 2026 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 321 | 48 | 35.2 | 34 | 105 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 39.5 | 40.8 | 53.6 | 48.9 | 39.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 710 | 573 | 507 | 609 | 619 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 760 | 705 | 677 | 666 | 710 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,562 | 1,456 | 1,330 | 1,336 | 1,393 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 432 | 361 | 320 | 380 | 376 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 960 | 849 | 759 | 789 | 826 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 602 | 607 | 571 | 547 | 567 |
| Total Liabilities & Shareholders' Equity | 1,562 | 1,456 | 1,330 | 1,336 | 1,393 |
| Total Common Shares Outstanding |